期刊文献+

免疫性血小板减少症患者淋巴细胞亚群表达及其与血小板抗体、临床特征的相关性研究 被引量:8

STUDY ON THE EXPRESSION AND CORRELATION OF LYMPHOCYTE SUBSETS TO PLATELET ANTIBODY AND CLINICAL characteristic IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA
原文传递
导出
摘要 目的研究免疫性血小板减少症(ITP)外周血淋巴细胞亚群表达及其相关性。方法用流式细胞术检测ITP及正常对照外周血淋巴细胞亚群,分析与血小板抗体、临床特征相关性。结果 ITP组CD19+显著增加,CD3+、CD3+CD4+、CD4+/CD8+、CD16+CD56+(NK细胞)显著降低(P<0.01);ITP组CD19+表达与其发病时间及就诊血小板数值呈正相关,NK细胞表达与其PAIgG水平呈负相关、与就诊血小板数值呈正相关(P<0.05)。结论除体液免疫参与ITP发病机制外,细胞免疫及NK细胞异常也与ITP发病有关。 Objective To investigate the expression and correlation of lymphocyte subsets to platelet antibody and clinical feature in patients with ITP. Methods The expression of lymphocyte subsets were measured by flow cytometry in 96 ITP patients and 45 normal subjects. Further, the correlation were ana- lyzed between the expression of lymphocyte subsets,platelet antibody and clinical feature. Results The ex- pression of CD19+ was higher in ITP patients than in normal controls, the expression of CD3+ , CD3+ CD4+ ,CD4+/CD8+ ,CD16+ CD56+ were lower in ITP patients than in normal controls (P〈0.01). The expression of CD19 + had positive correlation with the onset time and the number of platelet, the expression of CD16+ CD56+ had negative correlation with PAIgG and positive correlation with the number of platelet (P〈0.05). Conclusion The disorder of the cellular immunity and NK cells may be involved in the patho- genesis of ITP except humoral immunity function.
作者 张春梅
出处 《中国煤炭工业医学杂志》 2012年第10期1524-1526,共3页 Chinese Journal of Coal Industry Medicine
关键词 免疫性血小板减少症 淋巴细胞亚群 血小板抗体 临床特征 Immune thrombocytopenia Lymphocyte subsets Platelet antibody Clinical data
  • 相关文献

参考文献7

  • 1Syrijala H,Sureel HM, Ilonen J. Low CD4/CD8 lymphocyte ratio in acute myocardial infection[J]. Clin Exp Immunol, 1991,83:326 - 328.
  • 2Yoshimura C, Nomura S, Nagahama M, et al. Plasma - solu- ble Fas (APO-1, CD95) and soluble Fas ligand in immune thrombocytopenic purpura[J]. Eur J Haematol,2000,64 (4) : 219 - 224.
  • 3Provan D, Stasi R, Newland AC, et al. International consen sus report on the investigation and management of primary immune thromboeytopenia[J]. Blood, 2010,46 (115) : 168 - 186.
  • 4Rathmell JC, Cooke MP, Ho WY, et al. CD95 (Fas) - de pendent elimination of self '- relative B cells, upon interac tion with CIM + T cells[J]. Nature, 1995,376 : 181 - 184.
  • 5施菊妹,邵阳,胡晓静.自然杀伤细胞在血液系统肿瘤治疗中的应用[J].上海医学,2010,33(9):830-833. 被引量:6
  • 6Crossley AR, Dickinson AM, Proctor SJ, et al. Effects of in- terferon- alpha therapy on immune parameters in immune thrombocytopenic purpura [ J ]. Autoimrnunity, 1996,24 ( 2 ) : 81 - 100.
  • 7Johansson U,Macey MG,Kenny D,et al. The role of natural killerT(NKT) cells in immune thrombocytopenia., is strong in vitro NKT cell activity related to the development of remis- sion[J]. Br J Haematol, 2005,129 .. 564 - 565.

二级参考文献20

  • 1Caligiuri M A.Human natural killer cells.Blood,2008,112:461-469.
  • 2Cooper M A,Elliott J M,Keyel P A,et al.Cytokine-induced memory-like natural killer cells.Proc Natl Acad Sci U S A.2009,106:1915-1919.
  • 3Sun J C,Lanier L L.Natural killer cells remember:an evolutionary bridge between innate and adaptive immunity?Eur J Immunol,2009,39,2059-2064.
  • 4Empson V G,McQueen F M,Dalbeth N.The natural killer cell:a further innate mediator of gouty inflammation?Immunol Cell Biol,2010,88:24-31.
  • 5Sutlu T,Alici E.Natural killer cell-based immunotherapy in cancer:current insights and future prospects.J Intern Med,2009,266:154-181.
  • 6Kopecky J,Kopecky O.NK cells,chemokines and chemokine receptors.Klin Onkol,2010,23:5-9.
  • 7Farag S S,Caligiuri M A.Cytokine modulation of the innate immune system in the treatment of leukemia and lymphoma.Adv Pharmacol,2004,51:295-318.
  • 8De Sanctis J B,Mijares M,Suárez A,et al.Pharmacological properties of thalidomide and its analogues.Recent Pat Inflamm Allergy Drug Discov,2010,4:144-148.
  • 9Shi J,Tricot G J,Garg T K,et al.Bortezomib downregulates the cell-surface expression of HLA class I and enhances natural killer cell-mediated lysis of myeloma.Blood,2008,111:1309-1317.
  • 10Capietto A H,Keirallah S,Gross E,et al.Emerging concepts for the treatment of hematological malignancies with therapeutic monoclonal antibodies.Curr Drug Targets,2010,11:790-800.

共引文献5

同被引文献63

引证文献8

二级引证文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部